Provided by Tiger Trade Technology Pte. Ltd.

Dare Bioscience

0.8533
+0.03834.70%
Post-market: 0.8262-0.0271-3.18%18:29 EDT
Volume:278.07K
Turnover:234.40K
Market Cap:16.78M
PE:-1.10
High:0.8800
Open:0.8000
Low:0.7683
Close:0.8150
52wk High:3.78
52wk Low:0.6900
Shares:19.67M
Float Shares:17.33M
Volume Ratio:0.68
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7779
EPS(LYR):-1.1986
ROE:-2543.13%
ROA:-39.29%
PB:-29.92
PE(LYR):-0.71

Loading ...

DarÉ Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules

THOMSON REUTERS
·
Aug 15

Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire
·
Aug 15

VistaGen Q1 Revenue Rises on Licensing Agreement Expiration

Reuters
·
Aug 14

Dare Bioscience Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Dare Bioscience, Inc. Q2 EPS USD -0.2

THOMSON REUTERS
·
Aug 14

Dare Bioscience Q2 EPS $(0.20) Beats $(0.24) Estimate, Sales $187.546K Beat $2.000K Estimate

Benzinga Earnings
·
Aug 14

Daré Bioscience Q2 FY26 Net Loss Narrows to $2.98 Million; Revenue Rises to $187,546

Reuters
·
Aug 14

DarÉ Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances

THOMSON REUTERS
·
Aug 14

Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances

GlobeNewswire
·
Aug 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13

Dare Bioscience Inc Expected to Post a Loss of 24 Cents a Share - Earnings Preview

Reuters
·
Aug 12

Daré Bioscience to Host Quarterly Results Conference Call and Webcast

Reuters
·
Aug 06

DarÉ Bioscience Expands Access Options for Dare to Play™ and Specialized Menopause Care Through Strategic Collaboration with Mymenopauserx

THOMSON REUTERS
·
Jul 28

Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx

GlobeNewswire
·
Jul 28

Daré Bioscience, Inc. (NASDAQ:DARE): Are Analysts Optimistic?

Simply Wall St.
·
Jul 21

Daré Bioscience Launches Nationwide Virtual Bus Tour Webinar Series to Showcase Commercial Strategy and Growth Opportunities

GlobeNewswire
·
Jul 20

Daré Bioscience Advances DARE-HPV Trial, Raising New Questions for HPV Treatment Investors

TIPRANKS
·
Jul 18

Daré Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event

GlobeNewswire
·
Jul 09

Daré Bioscience Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform

GlobeNewswire
·
Jul 01

Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment

GlobeNewswire
·
Jun 25